Mackay Shields LLC’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-30,038
Closed -$3.84M 714
2022
Q1
$3.84M Sell
30,038
-2,108
-7% -$254K 0.03% 418
2021
Q4
$3.96M Sell
32,146
-722
-2% -$94.5K 0.03% 419
2021
Q3
$4.67M Sell
32,868
-950
-3% -$140K 0.04% 355
2021
Q2
$5.28M Sell
33,818
-2,072
-6% -$336K 0.05% 328
2021
Q1
$5.58M Buy
35,890
+137
+0.4% +$21.2K 0.04% 450
2020
Q4
$5.35M Sell
35,753
-603
-2% -$85.2K 0.04% 470
2020
Q3
$4.8M Sell
36,356
-1,351
-4% -$176K 0.03% 453
2020
Q2
$4.37M Buy
37,707
+2,435
+7% +$281K 0.03% 455
2020
Q1
$3.46M Buy
35,272
+542
+2% +$71K 0.03% 464
2019
Q4
$5.05M Sell
34,730
-12,130
-26% -$1.67M 0.03% 460
2019
Q3
$6.25M Sell
46,860
-11,214
-19% -$1.45M 0.04% 442
2019
Q2
$6.64M Sell
58,074
-16,831
-22% -$1.97M 0.05% 435
2019
Q1
$9.29M Buy
74,905
+844
+1% +$95.9K 0.07% 337
2018
Q4
$7.46M Buy
74,061
+27,868
+60% +$3.13M 0.06% 374
2018
Q3
$5.9M Buy
46,193
+11,954
+35% +$1.42M 0.05% 420
2018
Q2
$3.7M Sell
34,239
-2,729
-7% -$297K 0.03% 574
2018
Q1
$3.91M Buy
+36,968
New +$4.29M 0.02% 570

Other funds holding ZBH

Mackay Shields LLC's ZBH Position: Q2 2022 in Review

Mackay Shields LLC sold out of Zimmer Biomet (ZBH) in Q2 2022, closing a stake of 30,038 shares — an estimated $3.84M sold.

Mackay Shields LLC first reported a position in ZBH in Q1 2018 and held it in 17 quarters. The position peaked at $9.29M in Q1 2019. 956 funds tracked by Wall St. Rank hold ZBH as of Q2 2022.

  • Mackay Shields LLC reported no remaining Zimmer Biomet position as of Q2 2022 after selling out during the quarter.
  • Mackay Shields LLC sold 30,038 Zimmer Biomet shares in Q2 2022, an estimated $3.84M.
  • Mackay Shields LLC first reported a position in Zimmer Biomet in Q1 2018 and held it in 17 quarters.
  • Mackay Shields LLC's Zimmer Biomet position peaked at $9.29M in Q1 2019.
  • 956 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2022.

Based on Mackay Shields LLC's 13F filing for Q2 2022, filed 3 Aug 2022.